Skip to main content
Clinical Trials/NCT03868384
NCT03868384
Active, not recruiting
Not Applicable

Evaluation of Home Blood Pressure Measurement for the Management of Hypertension in Treated Hypertensive Patients

DongGuk University1 site in 1 country701 target enrollmentAugust 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hypertension
Sponsor
DongGuk University
Enrollment
701
Locations
1
Primary Endpoint
Difference of 24-hour blood pressure control rate
Status
Active, not recruiting
Last Updated
4 years ago

Overview

Brief Summary

Home blood pressure measurement has been reported to be associated with better clinic blood pressure and daytime blood pressure control. However, no study has evaluated the association between home blood pressure measurement and control of 24-hour ambulatory blood pressure in real world practice.

The purpose of the present study is to investigate the effect of home blood pressure measurement on the control of ambulatory blood pressure in the real world.

The detailed purposes of the present study are (1) to investigate the effects of home blood pressure measurement on the appropriate control of 24-hour ambulatory blood pressure in hypertensive patients treated with antihypertensive drug, (2) to evaluate the effect of home blood pressure measurement on the occurrence of cardiovascular events and target organ damage, (3) to investigate the status and appropriateness of home blood pressure measurement in the real world, and (4) to investigate factors of home blood pressure measurement methods affecting the treatment of hypertension.

Registry
clinicaltrials.gov
Start Date
August 1, 2018
End Date
December 31, 2026
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Moo-Yong Rhee

Professor

DongGuk University

Eligibility Criteria

Inclusion Criteria

  • Patients with hypertension and taking antihypertensive drugs more than 1 year

Exclusion Criteria

  • Secondary hypertension
  • Hypertensive emergency and urgency
  • Severe heart failure (NYHA III and IV)
  • Angina with 6 months
  • Myocardial infarction within 6 months
  • Peripheral artery disease within 6 months
  • Significant arrhythmia (i.e. ventricular tachycardia and fibrillation, atrial fibrillation, atrial flutter)
  • Pregnancy
  • Night labor, shift worker
  • Those who are currently participating in other clinical studies

Outcomes

Primary Outcomes

Difference of 24-hour blood pressure control rate

Time Frame: at baseline and 3 years of follow up

difference of 24-hour blood pressure control rate between patients who measure and do not measure home blood pressure

Secondary Outcomes

  • Difference of daytime blood pressure control rate(at baseline and 3 years of follow up)
  • Difference of office blood pressure control rate(at baseline and 3 years of follow up)
  • Difference of systolic and diastolic blood pressure (office, 24-hour, daytime, nighttime)(at baseline and 3 years of follow up)
  • Rate of home blood pressure measurement(at baseline and 3 years of follow up)
  • Reflection of home blood pressure(at baseline and 3 years of follow up)
  • cardiovascular disease prevalence and target organ damage(at baseline and 3 years of follow up)
  • Changes of home blood pressure measurement rate(from baseline to 3 years of follow up)
  • Cardiovascular disease events and target organ damage(during 3 years of follow up from baseline measurement)

Study Sites (1)

Loading locations...

Similar Trials